Clinical outcomes of immune checkpoint inhibitor combined with other targeted or immunological therapy regimens for the treatment of advanced bile tract cancer: a systematic review and meta-analysis
Article in Frontiers in Immunology (May 2024)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Unveiling the promise of PD1/PD-L1: A new dawn in immunotherapy for cholangiocarcinoma
Article in Biomedicine & Pharmacotherapy (April 2024)
Lenvatinib plus PD-1 inhibitors combined with chemotherapy versus lenvatinib plus PD-1 inhibitors for unresectable or recurrent biliary tract cancer
Preprint in Research Square (June 2023)